Monday, September 8, 2008

New Low-Dose Oral Contraceptive Yaz Launched in Europe

Bayer Schering Pharma´s YAZ® will be available across Europe as of September 2008. YAZ® is the first oral contraceptive containing 3 mg of the unique progestin drospirenone combined with 0.02 mg of ethinyl estradiol in a new dosing regimen of 24 days of active hormone tablets followed by 4 days of hormone-free tablets.

The details can be read here.

No comments: